- Low Potassium Dialysate Effective for Treating Hyperkalemia
- SEATTLE—A rigorous protocol for the use of low potassium dialysate may be effective for treating hyperkalemia in patients on hemodialysis (HD), researchers reported at the 2016 Annual Dialysis Conference. Investigators from Hamad General Hospital in ...
- FDA approves new drug to treat hyperkalemia
- The U.S. Food and Drug Administration today approved Veltassa (patiromer for oral suspension) to treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.
- The Burden of Hyperkalemia in Patients With Cardiovascular and Renal Disease
- Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk.
- Hyperkalemia Drugs: Questions Remain
- This communication came out in part as a result of some studies that were done with another, newer agent that the FDA recently approved for treatment of hyperkalemia called patiromer, which is Relypsa's product branded as Veltassa™.
Hyperkalemia is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Hyperkalemia books and related discussion.
Suggested News Resources
Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, realmagick.com library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.